FIELD: medicine and biochemistry.
SUBSTANCE: claimed method includes blood lymphocyte treatment with labeled fluorescein isothiocyanate of pea lectin isoform obtained by extraction of milled pea seeds with sodium chloride solution, purifying by undercooling, dialysis and isoform isolating by column chromatography on Sephadex, and elution with glucose-containing solution, and when number of labeled lymphocyte is lower than 50 % in contrast to normal one Ehrlich's carcinoma is diagnosed.
EFFECT: diagnosis method of increased specificity.
1 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SUPPRESSING CANCER TUMOR GROWTH | 1998 |
|
RU2159644C2 |
| METHOD FOR TREATING ONCOLOGICAL PATIENTS | 2004 |
|
RU2269356C2 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| MEDICINAL PREPARATION TO PREVENT TRANSPLANT DETACHMENT, MONOCLONAL ANTIBODY TO CD3 ANTIGEN OF HUMAN T-LYMPHOCYTES, HYBRIDOME AND METHOD TO TREAT PATIENTS SUFFERING ACUTE TRANSPLANT DETACHMENT REACTION FOLLOWING KIDNEY TRANSPLANTATION | 2000 |
|
RU2179862C1 |
| ANTI-TUMOUR AGENT | 2013 |
|
RU2541130C1 |
| ANTIVIRAL AGENT, VACCINE BASED ON THEREOF, METHOD OF ITS PREPARING, THERAPEUTIC AGENT AND METHOD OF DETECTION OF RNA-VIRUSES | 1990 |
|
RU2082417C1 |
| ANTIBODY FRAGMENTS SPECIFIC IN RELATION TO HUMAN CANCER-EMBRYONIC ANTIGEN (CEA) | 2003 |
|
RU2294939C2 |
| METHOD OF PRODUCING LYMPHOCYTES CYTO-TOXIC TO CANCER CELLS, AND METHOD OF PRODUCING GLYCO-BOUND SUBSTANCE | 0 |
|
SU1412596A3 |
| METHOD FOR PROPHYLAXIS OF ONCOLOGICAL DISEASES, OR INFECTIONS MORDIBIDIZED BY BACTERIA OR FUNGI AND PROTOZOA, OR ARTERIOSCLEROSIS, OR DIABETES MELLITUS, OR DISEASES MEDIATED BY DELAYED HYPERRESPONSIVENESS REACTION, OR DISEASES MEDIATED BY SOMATIC CELL GENE MUTATIONS (VARIANTS) | 2004 |
|
RU2269359C2 |
| METHOD TO PRODUCE ESTROGEN-BINDING PROTEIN ASSOCIATED WITH MALIGNANT TUMORS | 2012 |
|
RU2489440C1 |
